Vee Excel Drugs & Pharmaceuticals Ltd. v. Hab Pharmaceuticals & Research Lim.

CS (OS) No.1851/2008

Vee Excel Drugs & Pharmaceuticals Ltd. filed a suit seeking permanent injunction against Hab Pharmaceuticals & Research Lim., alleging infringement of its registered trademark 'Vega Asia' and associated copyrights in packaging designs. The defendant countered by asserting prior use, holding its own registrations (including the mark 'Vegah'), and crucially, arguing that the plaintiff had suppressed material facts regarding pending rectification applications and previous complaints. The Delhi High Court ultimately dismissed the plaintiff's interim injunction application, finding that the plaintiff's conduct disentitled them from relief at this stage.

Jurisdiction
India
Court
Delhi High Court
Case Number
CS (OS) No.1851/2008
Judge(s)
Manmohan Singh

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Vee Excel Drugs & Pharmaceuticals Ltd. vs Hab Pharmaceuticals & Research Lim. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCS(COMM) 505/2024

Malhotra Surgical IndustriesvsDharam Pal Singh Bhatia & Anr.

In this trademark infringement matter, the Delhi High Court issued interim directions concerning the online sale of 'MICROTONE' products. While the defendant undertook not to sell or distribute the impugned goods, the plaintiff noted that the products remained available on various e-commerce platforms. Consequently, the court directed both parties to file detailed affidavits—the plaintiff detailing current infringing listings and the defendants naming all distributors—to allow for further appropriate judicial action.

patentAID NO. 20 OF 2022

Guangdong Oppo Mobile Telecommunications Corp., Ltd.vsThe Controller of Patents and Designs

Oppo Mobile appealed the rejection of its patent application for a novel charging system and power adapter. The appellant contended that the rejection lacked reasons, failed to appreciate the requirements for novelty/inventiveness, and violated procedural rules by not issuing a Second Examination Report after amendments. The High Court allowed the appeal and remanded the matter back to the Controller for fresh consideration.

patentO.P.No.40 of 2019, etc., batch

R.Subbulakshmi (Deceased) & othersvs1/183 & others

This case involved complex disputes among the partners and legal heirs of a newspaper publishing firm, Dinamalar. The core issue revolved around the status and ownership of the firm's trademark following its dissolution. The Madras High Court addressed several related civil suits and original applications concerning partnership rights and intellectual property.

patent(T)CMA(PT)/169/2023

Erytech PharmavsThe Assistant Controller of Patents and Designs

Erytech Pharma filed a Transfer Civil Miscellaneous Appeal (Patents) challenging the Assistant Controller's decision regarding Indian Patent Application No. 661/CHENP/2010. The appellant subsequently sought and was granted leave to withdraw the appeal.

patentFAO (COMM) 60/2024

GTZ India Pvt. Ltd.vsArtek Surfins Chemicals Ltd. & Anr.

The Delhi High Court dismissed an appeal filed by GTZ India Pvt. Ltd. against a commercial court order that granted an injunction to Artek Surfins Chemicals Ltd. The dispute centered on the use of specific alphanumeric codes (e.g., '786', '2048M') in chemical products. The court found prima facie evidence that GTZ copied these unique alpha numerals, which are used by Artek as source identifiers for their goods, thereby establishing a case of both trademark infringement and passing off.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call